RxAll wins USAID grant to Africa for drug authentication platform

RxAll receives USAID grant to purchase a portable RxScanner platform that detects chemical compounds in products that use artificial Intelligence to verify their authenticity.

Screenshot 2022 01 22 4.07.29 PM

Consumer safety and economic growth in the developing world are threatened by low-quality counterfeit products. Low-quality medicines account for more than 10% of all medicines sold in developing countries. This results in annual losses of $21 billion. RxAll created RxScanner, handheld spectrometers that detect low-quality substances. This allows for the identification of compounds in products or medicines and sends reports to users.

The RxScanner can be used at pharmacies, and is smaller than traditional laboratory tests. The device is simple to use, even in low-resource environments and requires little technical knowledge.

Get latest news from African Startup ecosystem

Latest stories

You might also like...